Vishvas Garg

Vishvas Garg

AbbVie Inc - Chicago / United States
Economics & Econometrics / Economics
AD Scientific Index ID: 4402029
-
person_outline Vishvas Garg's MOST POPULAR ARTICLES
1-) Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the … JBJS 95 (4), 297-307, 2013
2-) Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the … Expert opinion on drug safety 13 (1), 15-23, 2014
3-) Risk of developing additional immune-mediated manifestations: a retrospective matched cohort study Advances in therapy 36, 1672-1683, 2019
4-) Economic impact of non-medical switching from originator biologics to biosimilars: a systematic literature review Advances in Therapy 36, 1851-1877, 2019
5-) Economic impact of non-medical switching from originator biologics to biosimilars: a systematic literature reviewY Liu, M Yang, V Garg, EQ Wu, J Wang, M SkupAdvances in Therapy 36, 1851-1877, 2019442019